Immunocore Hldgs

Biotechnology

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.

IMCR

Visualizar Fundamentos

Immunocore Hldgs

6,5

P/B

9,4

P/S

—

P/EBITDA

769,2

P/OCF

—

Forward P/E

9,2

BVPS

—

EPS